[PDF][PDF] 人类高致病性冠状病毒SARS-CoV 和MERS-CoV

代嫣嫣, 夏帅, 王茜, 陆路, 姜世勃 - 生命科学, 2016 - lifescience.sinh.ac.cn
SARS coronavirus spike glycoprotein mediates escape from a S2 domain-targeting neutralizing
monoclonal antibodycoronavirus: synergy and coverage of escape mutants. PLoS Med, …

2019 冠状病毒病(COVID-19) 概览

Y Shi, G Wang, X Cai, J Deng, L Zheng, H Zhu… - Journal of Zhejiang …, 2020 - Springer
Human monoclonal antibody combination against SARS coronavirus: synergy and
coverage of escape mutants. PLoS Med, 3(7):e237. https://doi.org/10.1371/journal.pmed.0030237 …

新型冠状病毒肺炎与传染性非典型肺炎特点及药物治疗的对比分析

朱愿超, 谭玲, 刘蕾, 李可欣, 齐文渊, 胡欣 - 临床药物治疗杂志, 2020 - 万方数据资源系统
… 据,比如阿比多尔在体外细胞实验有抑制SARSCoV-2 的作用,但尚无系统的临床研究… Human
monoclonal antibody combination against SARS coronavirus: synergy and coverage of escape

[PDF][PDF] 2020 年新型冠状病毒分子病理学研究及其药物和疫苗研发热点回眸

叶盛 - 科技导报, 2021 - kjdb.org
Human monoclonal antibody combination against SARS coronavirus: synergy and coverage
of escape … neutralization of SARS coronavirus isolates by human monoclonal antibodies[J]. …

治療性H7N9 禽流感病毒人源中和抗體之製作與驗證

陳宜萾 - 2015 - tdr.lib.ntu.edu.tw
… for binding assays of human anti-H7 monoclonal antibodies. … In addition, G63E and G234D
are also found in escape … inhibitors are likely to be synergistic since both entrance and …